Graybug GBV-102-002 Altissimo
Posted by: Georgia Retina in
Research Title: A Phase 2b Multicenter Dose-Ranging Study Evaluating the Safety and Efficacy of Sunitinib Malate Depot Formulation (GB-102) Compared to Aflibercept in Subjects With Neovascular (Wet) Age-related Macular Degeneration (ALTISSIMO Study) Sponsor: Graybug Vision Principal Investigator: Atul Sharma, M.D. Description: Phase 2b, multicenter, visual examiner-masked, randomized active-controlled, parallel-arm design study to evaluate the safety and duration of the…
Read More
HORIZON FVF3426g
Posted by: Georgia Retina in
Research Title: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO Sponsor: Genentech Principal Investigator: Jay Stallman, M.D. Description: This is an open-label, multicenter, extension study of intravitreally administered ranibizumab in subjects with primary or recurrent CNV secondary to AMD who have completed…
Read More AART C-02-60
Posted by: Georgia Retina in
Research Title: Anecortave Acetate Risk-Reduction Trial (AART) Sponsor: Allergan Principal Investigator: Atul Sharma, M.D. Description: A 48-month study of posterior juxtascleral administrations of Anecortave Acetate 15 or 30 mg or sham administration every 6 months. Start Date: March 2006 Recruitment: Completed Project Personnel: Leslie Marcus, CCRC Location(s): Riverdale; 155 Medical Way, Suite E, Riverdale, GA 30274
Read More Allergan 1771-201-008 MAPLE
Posted by: Georgia Retina in
Research Title: Evaluating Abicipar for Safety and Treatment Effect in Patients With Neovascular Age-related Macular Degeneration (AMD) Sponsor: Allergan Principal Investigator: Robert Stoltz, M.D., Ph.D. Description: The objective of this study is to evaluate abicipar for safety and treatment effect in patients with neovascular Age-related Macular Degeneration (AMD). Start Date: June 2018 Recruitment: Enrolling Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, CCRC,…
Read More ALLERGAN 206207-012
Posted by: Georgia Retina in
Research Title: Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema Sponsor: Allergan Principal Investigator: Robert Stoltz, M.D., Ph.D Description: This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone with laser treatment vs. laser treatment alone in patients with diabetic macular edema. Start Date: April 2007 Recruitment: Completed Project Personnel: Leslie…
Read More AREDS2
Posted by: Georgia Retina in
Research Title: Age-Related Eye Disease Study 2 (AREDS2) Sponsor: National Eye Institute (NEI) Principal Investigator: Jay Stallman, M.D. Description: AREDS2 is a multi-center randomized trial of approximately 4,200 participants designed to assess the effects of oral supplementation of high doses of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs (DHA and EPA) for the treatment of AMD and cataract….
Read More Acucela 4429-202 SEATTLE
Posted by: Georgia Retina in
Research Title: A Phase 2b/3 Multicenter, Randomized, Double-Masked, Dose-Ranging Study Comparing the Efficacy and Safety of Emixustat Hydrochloride (ACU-4429) With Placebo for the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration. Sponsor: Acucela Inc Principal Investigator: Mark J. Rivellese, M.D. Description: The purpose of this study is to determine if emixustat hydrochloride (ACU-4429) reduces the rate of…
Read More Aerpio AKB-9778-CI-5001 TIME-2b
Posted by: Georgia Retina in
Research Title: Phase 2 Double-Masked, Placebo-Controlled Study to Assess the Safety and Efficacy of Subcutaneously Administered AKB-9778 15mg Once Daily or 15mg Twice Daily for 12 Months in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy Sponsor: Aerpio Therapeutics, LLC Principal Investigator: Sri Krishna Mukkamala, M.D. Description: The purpose of this study is to evaluate the safety and efficacy…
Read More Allergan 150998-005 CEDAR
Posted by: Georgia Retina in
Research Title: A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-Related Macular Degeneration Sponsor: Allergan Principal Investigator: Robert A. Stoltz, M.D., Ph.D. Description: This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration. Start Date: October 2015 Recruitment: Complete Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, CCRC, COA; Stephanie Campbell, CRC,…
Read More Allergan 190342-038 BEACON
Posted by: Georgia Retina in
Research Title: A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration. Sponsor: Allergan Principal Investigator: Mark J. Rivellese, M.D. Description: This study will assess the safety and efficacy of the brimonidine intravitreal implant in patients with geographic atrophy due to age-related macular degeneration. Start Date: December 2015 Recruitment: Completed Project Personnel: Leslie Marcus, CCRC;…
Read More 
